Paper42123718
Systematic Review of Monocyte Transcriptomic Profiles as Diagnostic and Prognostic Biomarkers in Colorectal Cancer.
Podadera-Herreros A and 11 others. Int J Mol Sci, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Systematic Review of Monocyte Transcriptomic Profiles as Diagnostic and Prognostic Biomarkers in Colorectal Cancer. Papers, record 42123718. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42123718
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Systematic Review of Monocyte Transcriptomic Profiles as Diagnostic and Prognostic Biomarkers in Colorectal Cancer.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Monocytes | Major topic |
| Transcriptome | Major topic |
| Humans | |
| Prognosis | |
| Gene Expression Profiling | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CD25/00152 | Institute of Health Carlos III | PubMed | ||
| CD21/000131 | Institute of Health Carlos III | PubMed | ||
| PFIS-FI25/00135 | Institute of Health Carlos III | PubMed | ||
| RYC2024-048209-I | Agencia Estatal de Investigación | PubMed | ||
| PI24/00061 | Institute of Health Carlos III | PubMed | ||
| RC-0001-2018 and C-0029-2014 | Andalusian Health Service | PubMed | ||
| CD23/00111 | Institute of Health Carlos III | PubMed | ||
| CPII21/00013 | Institute of Health Carlos III | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,773,143 | Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer. | Nat Commun | 2024 | https://conductscience.org/library/papers/38773143 | PubMed |
| 2 | 32,900,991 | Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32900991 | PubMed |
| 3 | 29,794,753 | The predictive value and the correlation of peripheral absolute monocyte count, tumor-associated macrophage and microvessel density in patients with colon cancer. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/29794753 | PubMed |
| 4 | 27,061,264 | Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins. | Mol Carcinog | 2017 | https://conductscience.org/library/papers/27061264 | PubMed |
| 5 | 32,702,383 | Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2020 | https://conductscience.org/library/papers/32702383 | PubMed |
| 6 | 35,836,930 | Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35836930 | PubMed |
| 7 | 30,178,033 | PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. | Ann Intern Med | 2018 | https://conductscience.org/library/papers/30178033 | PubMed |
| 8 | 33,524,598 | Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/33524598 | PubMed |
| 9 | 33,591,628 | Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression. | Cancer Med | 2021 | https://conductscience.org/library/papers/33591628 | PubMed |
| 10 | 26,035,703 | Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. | Br J Cancer | 2015 | https://conductscience.org/library/papers/26035703 | PubMed |
| 11 | 18,511,927 | Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. | Nat Rev Drug Discov | 2008 | https://conductscience.org/library/papers/18511927 | PubMed |
| 12 | 34,999,169 | Decreased CXCR2 expression on circulating monocytes of colorectal cancer impairs recruitment and induces Re-education of tumor-associated macrophages. | Cancer Lett | 2022 | https://conductscience.org/library/papers/34999169 | PubMed |
| 13 | 40,702,585 | Epigenomic preconditioning of peripheral monocytes determines their transcriptional response to the tumor microenvironment. | Genome Med | 2025 | https://conductscience.org/library/papers/40702585 | PubMed |
| 14 | 39,376,564 | Increased neutrophil counts are associated with poor overall survival in patients with colorectal cancer: a five-year retrospective analysis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39376564 | PubMed |
| 15 | 41,514,627 | Tumor-Immune Cell Crosstalk Drives Immune Cell Reprogramming Towards a Pro-Tumor Proliferative State Involving STAT3 Activation. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41514627 | PubMed |
| 16 | 30,718,435 | Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30718435 | PubMed |
| 17 | 36,733,385 | PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse. | Front Immunol | 2022 | https://conductscience.org/library/papers/36733385 | PubMed |
| 18 | 32,606,968 | Biochemical Markers of Colorectal Cancer - Present and Future. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32606968 | PubMed |
| 19 | 38,729,966 | Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38729966 | PubMed |
| 20 | 41,239,247 | Global burden of colorectal cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41239247 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CXCR2 | 3,579 | PubTator's text mining | https://conductscience.org/library/genes/3579 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42123718
GET https://conductscience.org/api/papers/v1/42123718/references?page=2